Malaweera A, Huang L, McMahon L
J Clin Med. 2025; 14(4).
PMID: 40004925
PMC: 11857055.
DOI: 10.3390/jcm14041395.
Chen B, Zhang Q, Wang S, Guan X, Luo W, Li D
Parasit Vectors. 2024; 17(1):446.
PMID: 39478572
PMC: 11526643.
DOI: 10.1186/s13071-024-06458-4.
Meijers B, Zadora W, Lowenstein J
Toxins (Basel). 2024; 16(5).
PMID: 38787079
PMC: 11126090.
DOI: 10.3390/toxins16050227.
Matsuoka T, Abe M, Kobayashi H
Int J Mol Sci. 2024; 25(7).
PMID: 38612557
PMC: 11012052.
DOI: 10.3390/ijms25073745.
Rahman W, Rabea I, Meizel M
J Med Life. 2023; 16(9):1310-1315.
PMID: 38107705
PMC: 10719797.
DOI: 10.25122/jml-2023-0128.
The AKI-to-CKD Transition: The Role of Uremic Toxins.
Andre C, Bodeau S, Kamel S, Bennis Y, Caillard P
Int J Mol Sci. 2023; 24(22).
PMID: 38003343
PMC: 10671582.
DOI: 10.3390/ijms242216152.
Animal Models for Studying Protein-Bound Uremic Toxin Removal-A Systematic Review.
Ahmed S, Vries J, Lu J, Stuart M, Mihaila S, Vernooij R
Int J Mol Sci. 2023; 24(17).
PMID: 37686004
PMC: 10487432.
DOI: 10.3390/ijms241713197.
Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study.
Wiese G, Biruete A, Stremke E, Lindemann S, Jannasch A, Moorthi R
J Ren Nutr. 2023; 34(1):26-34.
PMID: 37468049
PMC: 10792123.
DOI: 10.1053/j.jrn.2023.06.011.
Phosphoproteomic Approaches for Identifying Phosphatase and Kinase Substrates.
DeMarco A, Hall M
Molecules. 2023; 28(9).
PMID: 37175085
PMC: 10180314.
DOI: 10.3390/molecules28093675.
Uremic Toxin-Producing Species Prevail in the Gut Microbiota of Taiwanese CKD Patients: An Analysis Using the New Taiwan Microbiome Baseline.
Shivani S, Kao C, Chattopadhyay A, Chen J, Lai L, Lin W
Front Cell Infect Microbiol. 2022; 12:726256.
PMID: 35558102
PMC: 9086402.
DOI: 10.3389/fcimb.2022.726256.
The Evolving View of Uremic Toxicity.
Meijers B, Lowenstein J
Toxins (Basel). 2022; 14(4).
PMID: 35448883
PMC: 9031373.
DOI: 10.3390/toxins14040274.
What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
Vanholder R, Nigam S, Burtey S, Glorieux G
Toxins (Basel). 2022; 14(3).
PMID: 35324718
PMC: 8953523.
DOI: 10.3390/toxins14030221.
Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature.
Brydges C, Fiehn O, Mayberg H, Schreiber H, Mahmoudian Dehkordi S, Bhattacharyya S
Sci Rep. 2021; 11(1):21011.
PMID: 34697401
PMC: 8546034.
DOI: 10.1038/s41598-021-99845-1.
Gaining Insights Into Metabolic Networks Using Chemometrics and Bioinformatics: Chronic Kidney Disease as a Clinical Model.
Boccard J, Schvartz D, Codesido S, Hanafi M, Gagnebin Y, Ponte B
Front Mol Biosci. 2021; 8:682559.
PMID: 34055893
PMC: 8163225.
DOI: 10.3389/fmolb.2021.682559.
Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial.
Kee Y, Han S, Kang D, Noh J, Jeong K, Kim G
Yonsei Med J. 2020; 62(1):41-49.
PMID: 33381933
PMC: 7820454.
DOI: 10.3349/ymj.2021.62.1.41.
Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease.
Nagata D, Yoshizawa H
Int J Nephrol Renovasc Dis. 2020; 13:359-365.
PMID: 33311993
PMC: 7726832.
DOI: 10.2147/IJNRD.S287237.
Encapsulation of Activated Carbon into a Hollow-Type Spherical Bacterial Cellulose Gel and Its Indole-Adsorption Ability Aimed at Kidney Failure Treatment.
Hoshi T, Endo M, Hirai A, Suzuki M, Aoyagi T
Pharmaceutics. 2020; 12(11).
PMID: 33187079
PMC: 7696591.
DOI: 10.3390/pharmaceutics12111076.
Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics.
Gagnebin Y, Jaques D, Rudaz S, de Seigneux S, Boccard J, Ponte B
Sci Rep. 2020; 10(1):19502.
PMID: 33177589
PMC: 7658362.
DOI: 10.1038/s41598-020-76524-1.
The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice.
Yesbolatova A, Saito Y, Kitamoto N, Makino-Itou H, Ajima R, Nakano R
Nat Commun. 2020; 11(1):5701.
PMID: 33177522
PMC: 7659001.
DOI: 10.1038/s41467-020-19532-z.
Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.
Hamza E, Metzinger L, Metzinger-Le Meuth V
Cells. 2020; 9(9).
PMID: 32899941
PMC: 7565991.
DOI: 10.3390/cells9092039.